Incisional recurrences after endometrial cancer surgery

Giorgio Bogani, Sean Christopher Dowdy, William Arthur Cliby, Bobbie S. Gostout, Sanjeev Kumar, Fabio Ghezzi, Francesco Multinu, Andrea Mariani

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Aim: The aim of the present study was to estimate the incisional recurrence (IR) rate after endometrial cancer (EC) staging surgery and analyze characteristics of affected patients. Patients and Methods: We retrospectively searched for patients with EC at 2 institutions and analyzed the occurrence of IR after open, laparoscopic, or robotic surgery. Additionally, a review of the literature was performed. Results: Out of 2,636 patients with EC, 1,732 (65.7%), 461 (17.5%), and 443 (16.8%) had open, laparoscopic, and robotic surgery, respectively. Only 3 patients (0.11%) had IR, all after open surgery. Additionally, 38 cases of IR were identified from the literature. Patients with non-isolated IR had worse overall survival than patients with isolated IR (p=0.04). Among this latter group, combined treatments may be associated with improved survival outcome. Conclusion: IR after EC surgery is rare and may occur after minimally-invasive or open operations. Combination of local and systemic treatments may provide favorable outcomes for patients with isolated IR.

Original languageEnglish (US)
Pages (from-to)6097-6104
Number of pages8
JournalAnticancer Research
Volume35
Issue number11
StatePublished - Nov 1 2015

Keywords

  • Endometrial cancer
  • Incisional recurrence
  • Laparoscopy
  • Open surgery
  • Port site metastases

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Incisional recurrences after endometrial cancer surgery'. Together they form a unique fingerprint.

  • Cite this

    Bogani, G., Dowdy, S. C., Cliby, W. A., Gostout, B. S., Kumar, S., Ghezzi, F., Multinu, F., & Mariani, A. (2015). Incisional recurrences after endometrial cancer surgery. Anticancer Research, 35(11), 6097-6104.